Carl Sterritt


Carl has over 25 years of experience in the pharmaceutical industry as an entrepreneur and executive.  Carl was the Founder and CEO of Shield Therapeutics plc, with primary responsibility for the creation and delivery of the Company’s strategy, its fund-raising activities as well as being the primary investor contact. 


Key achievements included raising c. $150m of investment; asset acquisition; leading the development and US/EU approval of Shield’s primary asset and then executing outbound licensing agreements.  He has extensive investor, analyst, shareholder and media experience and has had demonstrable success in building experienced, robust and adaptable organisations with ‘can do’ cultures that successfully deal with complex issues common to a growing and ambitious entrepreneurial business.